Topical therapy in the management of pediatric eczema: Evidence-based review
Indian Journal of Skin Allergy · 18.03.2026 · 5 · 9-16
DOI: 10.25259/ijsa_26_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Skin Allergy, online erschienen am 18.03.2026. Verfasst von Nibedita Dixit und 2 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Atopic dermatitis (AD) is a chronic inflammatory skin disorder marked by recurrent flares and remissions, with intense and persistent pruritus and variable clinical presentation. The primary therapeutic objectives are to reduce skin lesions, minimize flare-ups, and decrease overall disease burden. Topical corticosteroids and topical calcineurin inhibitors remain central to topical management in pediatric AD. However, due to long-term side effects, continuous use is not recommended. Hence, recent advancements have shifted toward novel and targeted topical therapies, which show potential in improving disease outcomes in mild-to-moderate AD. Nevertheless, long-term, large-scale studies are essential to fully assess their safety and efficacy. This consensus document aims to update the general management and upcoming therapies in pediatric AD.
Zitieren
APA
Dixit, N., Varma, S. D. M., & Samal, A. (2026). Topical therapy in the management of pediatric eczema: Evidence-based review. Indian Journal of Skin Allergy, 5, 9-16. https://doi.org/10.25259/ijsa_26_2025
Vancouver
Dixit N, Varma SDM, Samal A. Topical therapy in the management of pediatric eczema: Evidence-based review. Indian Journal of Skin Allergy. 2026;5:9-16. doi:10.25259/ijsa_26_2025
BibTeX
@article{Dixit2026,
author = {Dixit, Nibedita and Varma, Sri Dantuluri Midhun and Samal, Abhipsa},
title = {Topical therapy in the management of pediatric eczema: Evidence-based review},
journal = {Indian Journal of Skin Allergy},
year = {2026},
volume = {5},
pages = {9--16},
doi = {10.25259/ijsa_26_2025}
}
EUVIMED